Results: 19

Drogas Imunossupressoras
Immunosuppressive drugs

Does the association of tacrolimus and mycophenolate mofetil change the healing of the abdominal wall? study in rats submitted to ischemia and kidney reperfusion

ABCD (São Paulo, Impr.); 33 (4), 2020
ABSTRACT Background: Tacrolimus and mycophenolate mofetil are immunosuppressive agents widely used on the postoperative period of the transplants. Aim: To evaluate the influence of the association of them on the abdominal wall healing in rats. Methods: Thirty-six Wistar rats were randomly assigned ...

Manejo de pacientes con enfermedad inflamatoria intestinal durante la pandemia de COVID-19

Rev. colomb. gastroenterol; 35 (supl.1), 2020
La pandemia causada por el virus SARS-CoV-2, originada en Wuhan, capital de la provincia de Hubei (China), se ha convertido en un desafío para la humanidad. Es un virus altamente contagioso; hasta el momento, la enfermedad por coronavirus (COVID-19) presenta una mortalidad global alrededor del 6 %, que ...

Mitigating effect of tanshinone IIA on ventricular remodeling in rats with pressure overload-induced heart failure

Acta cir. bras; 34 (8), 2019
Abstract Purpose To investigate the effect of tanshinone IIA (TIIA) on ventricular remodeling in rats with pressure overload-induced heart failure. Methods Pressure overload-induced heart failure model (abdominal aortic coarctation) was established in 40 rats, which were divided into model and 5, 10 an...

Improvement of nailfold capillary microangiopathy after immunosuppressant therapy in a child with clinically amyopathic juvenile dermatomyositis

Rev. bras. reumatol; 57 (5), 2017

Polimorfismos em genes envolvidos na farmacodinâmica de tacrolimo e everolimo e sua relação com a resposta ao tratamento imunossupressor, em receptores de transplante renal

O monitoramento de imunossupressores, como os inibidores de calcineurina ou de mTOR, é essencial para evitar desfechos clínicos desfavoráveis, em receptores de transplante renal. Polimorfismos em genes envolvidos na farmacocinética têm sido associados com variabilidade na resposta a imunossupressore...

First- Versus Second-Generation Drug-Eluting Stents in Acute Coronary Syndromes (Katowice-Zabrze Registry)

Arq. bras. cardiol; 106 (5), 2016
Abstract Background: There are sparse data on the performance of different types of drug-eluting stents (DES) in acute and real-life setting. Objective: The aim of the study was to compare the safety and efficacy of first- versus second-generation DES in patients with acute coronary syndromes (ACS). M...

Presente y futuro de la terapia inmunosupresora
[Present and future of immunosuppressive therapy]

Medicina (B.Aires); 60 (1), 2000
Immunosuppressive drugs make possible the acceptance of organ allografts among individuals with differences in Major Histocompatibility Antigens (HLA). Transplantation of vital organs prolongs the survival of patients with terminal diseases, and this procedure has become a routine practice in the clinic,...